Asymmetry Capital Management as of Sept. 30, 2017
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 32 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ptc Therapeutics I (PTCT) | 8.2 | $7.1M | 356k | 20.01 | |
| Centene Corporation (CNC) | 7.8 | $6.8M | 70k | 96.77 | |
| Insmed (INSM) | 7.7 | $6.7M | 213k | 31.21 | |
| Jazz Pharmaceuticals (JAZZ) | 7.1 | $6.2M | 42k | 146.25 | |
| UnitedHealth (UNH) | 5.7 | $4.9M | 25k | 195.83 | |
| Sarepta Therapeutics (SRPT) | 5.5 | $4.8M | 105k | 45.36 | |
| Bio-Rad Laboratories (BIO) | 5.2 | $4.5M | 20k | 222.21 | |
| Quest Diagnostics Incorporated (DGX) | 4.2 | $3.6M | 38k | 93.64 | |
| Acadia Healthcare (ACHC) | 4.0 | $3.5M | 73k | 47.76 | |
| Amicus Therapeutics (FOLD) | 3.7 | $3.2M | 213k | 15.08 | |
| Neurocrine Biosciences (NBIX) | 3.7 | $3.2M | 52k | 61.29 | |
| Natera (NTRA) | 3.5 | $3.1M | 237k | 12.89 | |
| Ionis Pharmaceuticals (IONS) | 3.3 | $2.8M | 56k | 50.69 | |
| HMS Holdings | 3.3 | $2.8M | 142k | 19.86 | |
| Invitae (NVTAQ) | 3.2 | $2.8M | 294k | 9.37 | |
| Tactile Systems Technology, In (TCMD) | 3.0 | $2.6M | 83k | 30.95 | |
| Nightstar Therapeutics | 2.9 | $2.5M | 130k | 19.20 | |
| DURECT Corporation | 1.8 | $1.6M | 888k | 1.77 | |
| Juno Therapeutics | 1.6 | $1.4M | 31k | 44.86 | |
| Inogen (INGN) | 1.6 | $1.3M | 14k | 95.09 | |
| Alder Biopharmaceuticals | 1.5 | $1.3M | 105k | 12.25 | |
| Medtronic (MDT) | 1.5 | $1.3M | 16k | 77.75 | |
| Clovis Oncology | 1.3 | $1.2M | 14k | 82.38 | |
| Nevro (NVRO) | 1.2 | $1.1M | 12k | 90.90 | |
| Tivity Health | 1.2 | $1.0M | 26k | 40.81 | |
| Heron Therapeutics (HRTX) | 1.2 | $1.0M | 63k | 16.15 | |
| Regeneron Pharmaceuticals (REGN) | 1.2 | $998k | 2.2k | 446.93 | |
| Sienna Biopharmaceuticals (SNNAQ) | 1.1 | $926k | 42k | 22.25 | |
| Aerie Pharmaceuticals | 1.0 | $874k | 18k | 48.62 | |
| Synergy Pharmaceuticals | 0.9 | $786k | 271k | 2.90 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $443k | 13k | 32.94 | |
| Combimatrix Corporation | 0.3 | $245k | 33k | 7.51 |
